Literature DB >> 7525129

Influence of an established acute phase response on the severity of experimental nephritis.

A M Karkar1, A J Rees.   

Abstract

Small doses of lipopolysaccharide (LPS) induced an acute phase response (APR), and a number of studies have also shown that this greatly enhances the severity of glomerular injury in the heterologous phase of nephrotoxic nephritis (hNTN), an experimental model of anti-glomerular basement membrane (GBM) disease. Here, we examined the influence of pre-existing subclinical infection and raised APR, assessed by plasma alpha 2-macroglobulin (alpha 2-M) concentration, on the degree of injury in this model of nephritis. Studies were initially performed to determine the normal range of alpha 2-M in rats and its modulation by IL-6 and different doses of LPS. Plasma concentration of alpha 2-M was found to be variable and dependent on the weight of the rats. Single injections of either LPS or IL-6 had a comparable effect, and continuous perfusions of LPS caused a progressive increase in alpha 2-M which peaked at 48 h and declined gradually over 1 week. Following induction of nephritis with 10 mg of anti-GBM antibody, rats with raised alpha 2-M had 14 +/- 3 mg/24 h albuminuria compared with 4 +/- 1 mg/24 h in rats with normal alpha 2-M (P < 0.001, Wilcoxon). Injection of 20 mg anti-GBM antibody caused 36 +/- 11 mg/24 h albuminuria compared with 16 +/- 4 mg/24 h (P < 0.001), respectively. However, all these rats remained active and none of them died. In contrast, injection of 0.25 microgram LPS before induction of nephritis with 10 mg anti-GBM antibody, in rats with raised alpha 2-M, caused severe albuminuria (115 +/- 23 mg/24 h) compared with rats having normal levels of alpha 2-M (72 +/- 15 mg/24 h, P < 0.05). Furthermore, rats with raised alpha 2-M also had severe systemic manifestations characterized by pulmonary haemorrhage and extensive glomerular thrombosis, and many of them died. These results demonstrate the potential effect of pre-existing subclinical infection and raised APR on severity of glomerular injury which may affect the outcome of experimental studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525129      PMCID: PMC1534417          DOI: 10.1111/j.1365-2249.1994.tb06140.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1.

Authors:  N I Tomosugi; S J Cashman; H Hay; C D Pusey; D J Evans; A Shaw; A J Rees
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

3.  Radioimmunoassay of rat acute-phase alpha 2-macroglobulin.

Authors:  D E Panrucker; F L Lorscheider
Journal:  Biochim Biophys Acta       Date:  1982-07-26

4.  The rapid isolation of ribonuclease-free immunoglobulin G by protein A-sepharose affinity chromatography.

Authors:  T J Miller; H O Stone
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

5.  Changes in the blood level and affinity to concanavalin A of rat plasma glycoproteins during acute inflammation and hepatoma growth.

Authors:  A Koj; A Dubin; H Kasperczyk; J Bereta; A H Gordon
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

6.  Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha.

Authors:  G Ramadori; J Van Damme; H Rieder; K H Meyer zum Büschenfelde
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

7.  Recombinant human IL-6 expressed in E. coli undergoes selective N-terminal degradation: evidence that the protein consists of a stable core and a nonessential flexible N-terminal.

Authors:  A E Proudfoot; S C Brown; A R Bernard; J Y Bonnefoy; E H Kawashima
Journal:  J Protein Chem       Date:  1993-08

8.  Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins.

Authors:  T Andus; T Geiger; T Hirano; T Kishimoto; P C Heinrich
Journal:  Eur J Immunol       Date:  1988-05       Impact factor: 5.532

9.  Rat alpha2 acute-phase macroglobulin. Isolation and physicochemical properties.

Authors:  F Gauthier; H Mouray
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

10.  Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.

Authors:  J Van Damme; G Opdenakker; R J Simpson; M R Rubira; S Cayphas; A Vink; A Billiau; J Van Snick
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.